Synthesis of Calcium Phosphate Microspheres Using an Ultrasonic Spray–Pyrolysis Technique and Their Application as Novel Anti-Angiogenic Chemoembolization Agents for Cancer Treatment
Synthesis of Calcium Phosphate Microspheres Using an Ultrasonic Spray–Pyrolysis Technique and Their Application as Novel Anti-Angiogenic Chemoembolization Agents for Cancer Treatment
复制标题
超声喷雾热解技术合成磷酸钙微球及其作为新型抗血管生成化疗栓塞剂在癌症治疗中的应用
DOI:
10.1021/bk-2017-1253.ch006
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
M. Emoto
中科院分区:
文献类型:
--
作者:
M. Aizawa;M. Honda;M. Emoto
The purpose of the present study was to develop a novel process for chemoembolization to improve the therapeutic effectiveness and safety profile of cancer treatment. A chemoembolization approach was designed for treating human solid tumors using biodegradable calcium phosphate microspheres (hereafter, CPMs) prepared using an ultrasonic spray–pyrolysis technique combined with an anti-angiogenic agent (TNP-470; Takeda, Japan) that inhibits tumor vasculature formationin vivo. FU-MMT-3 human uterine sarcoma cells were used in this study because this type of tumor is aggressive and responds poorly to radiotherapy and currently used chemotherapy agents. In this chapter, preparation of biodegradable CPMs and their powder properties, including drug release characteristics, will be reviewed. We performed biological evaluations bothin vitroandin vivousing CPMs loaded with TNP-470. The results of these tests indicated that microspheres loaded with TNP-470 inhibit i) the proliferation of FU-MMT-3 cells in a tumor model and ii) tumor enlargement in a model of nude mice injected with FU-MMT-3 cells. Biological evaluations demonstrated that CPMs loaded with TNP-470 exhibit excellent anti-tumorigenic effects. In addition to the above, this chapter will discuss i) the effects of particle size and CPM distribution on anti-angiogenic chemoembolization, ii) the creation of porous advanced carrier CPMs with nano-pores on the surface prepared via salt-assisted ultrasonic spray–pyrolysis, and iii) our future work.
登录
查看更多内容
影响因子:
5.7
作者:
M. Emoto;K. Tachibana;H. Iwasaki;T. Kawarabayashi
通讯作者:
M. Emoto;K. Tachibana;H. Iwasaki;T. Kawarabayashi
DOI:
10.1111/j.1151-2916.1991.tb07132.x
发表时间:
1991-07-01
影响因子:
3.9
作者:
HENCH, LL
通讯作者:
HENCH, LL
DOI:
--
发表时间:
2004
期刊:
Gynecol Oncol 95
影响因子:
--
作者:
Emoto;M.
通讯作者:
M.
影响因子:
14
作者:
Kawashita, M;Shineha, R;Sawada, Y
通讯作者:
Sawada, Y
DOI:
--
发表时间:
2004
期刊:
Cancer Lett 203
影响因子:
--
作者:
Miura;S.
通讯作者:
S.